The word "feminist" still raises hackles. Is
claiming this word all about age, race, and class?
-Women to Watch
Those entering middle age are discovering--sometimes too
late--that women get the short end of the stick when it
comes to retirement benefits.
-Women's Bodies are Finally Being Studied
Making mifepristone available in this country took decades
of struggle and remains fraught with controversy.
-The Guerilla Girls
Lesbian society in Paris at the turn of the 20th century
is captured by this groundbreaking portraitist.
Women: Rosario Robles' Bold Agenda
Serpent Slayer by Katrin Tchana, Illustrated
by Trina Schart Hyman
Goes And Gets Some, Emily Carter
Moon Pearl, Ruthanne Lum McCunn
My Tiara, Susan Jane Gilman
Tattoos, Mira Kamdar
Person: By Any Other Name
-Columns: Daisy Hernandez, Patricia Smith and Gloria
EXCERPT FROM MS. MAGAZINE
a decade of successful use in Europe and a protracted
tug-of-war here, mifepristone is at long last available
to women in the U.S. On the surface, this option seems
straightforward enough-a way to end early pregnancy
by taking two drugs over the course of three days. It
will provide women and girls with an alternative to
surgery for the approximately 1.4 million abortions
that occur in the U.S. every year.
mifepristone's arrival has fueled fervor on both sides
of the abortion debate. Already fettered by existing
waiting-period and parental-consent laws, it has also
inspired new anti-choice legislation. Requiring extensive
medical protocols, the drug is too expensive for many
women to afford. But despite its drawbacks, many women's
health advocates are applauding mifepristone's arrival.
The drug has the potential to improve access to abortion,
boosting the number of doctors who offer it and frustrating
the efforts of anti-choice militants. As Gloria Feldt,
president of Planned Parenthood Federation of America,
says, "This is the first truly major technological breakthrough
for women's reproductive health care since the birth
control pill was introduced in 1960."